200 related articles for article (PubMed ID: 37515959)
1. Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications.
Abdellatif AAH; Scagnetti G; Younis MA; Bouazzaoui A; Tawfeek HM; Aldosari BN; Almurshedi AS; Alsharidah M; Rugaie OA; Davies MPA; Liloglou T; Ross K; Saleem I
Colloids Surf B Biointerfaces; 2023 Sep; 229():113466. PubMed ID: 37515959
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of non-coding RNAs in cancer.
Slaby O; Laga R; Sedlacek O
Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
[TBL] [Abstract][Full Text] [Related]
3. Noncoding RNAs in cancer therapy resistance and targeted drug development.
Wang WT; Han C; Sun YM; Chen TQ; Chen YQ
J Hematol Oncol; 2019 Jun; 12(1):55. PubMed ID: 31174564
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs as therapeutic targets in hepatocellular cancer.
Braconi C; Patel T
Curr Cancer Drug Targets; 2012 Nov; 12(9):1073-80. PubMed ID: 22873215
[TBL] [Abstract][Full Text] [Related]
5. Chitosan nanocarriers for non-coding RNA therapeutics: A review.
Karthik S; Mohan S; Magesh I; Bharathy A; Kolipaka R; Ganesamoorthi S; Sathiya K; Shanmugavadivu A; Gurunathan R; Selvamurugan N
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130361. PubMed ID: 38395284
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs and other non-coding RNAs as targets for anticancer drug development.
Ling H; Fabbri M; Calin GA
Nat Rev Drug Discov; 2013 Nov; 12(11):847-65. PubMed ID: 24172333
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.
Li X; Qi H; Cui W; Wang Z; Fu X; Li T; Ma H; Yang Y; Yu T
Mol Ther; 2022 Oct; 30(10):3118-3132. PubMed ID: 35918894
[TBL] [Abstract][Full Text] [Related]
8. The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma.
Fattore L; Mancini R; Ascierto PA; Ciliberto G
Expert Opin Ther Targets; 2019 Jan; 23(1):53-68. PubMed ID: 30507327
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
Ling H
Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
[TBL] [Abstract][Full Text] [Related]
10. Next RNA Therapeutics: The Mine of Non-Coding.
Garbo S; Maione R; Tripodi M; Battistelli C
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806476
[TBL] [Abstract][Full Text] [Related]
11. Targeting non-coding RNAs to overcome cancer therapy resistance.
Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
[TBL] [Abstract][Full Text] [Related]
12. ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.
Hueso M; Mallén A; Suñé-Pou M; Aran JM; Suñé-Negre JM; Navarro E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769025
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
Poller W; Tank J; Skurk C; Gast M
Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
[TBL] [Abstract][Full Text] [Related]
14. Exploring clinical implications and role of non-coding RNAs in lung carcinogenesis.
Roy S; Ganguly N; Banerjee S
Mol Biol Rep; 2022 Jul; 49(7):6871-6883. PubMed ID: 35076850
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics.
Paramanantham A; Asfiya R; Das S; McCully G; Srivastava A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362424
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanocarriers for microRNA delivery.
Scheideler M; Vidakovic I; Prassl R
Chem Phys Lipids; 2020 Jan; 226():104837. PubMed ID: 31689410
[TBL] [Abstract][Full Text] [Related]
17. Unlocking the potential of non-coding RNAs in cancer research and therapy.
Uppaluri KR; Challa HJ; Gaur A; Jain R; Krishna Vardhani K; Geddam A; Natya K; Aswini K; Palasamudram K; K SM
Transl Oncol; 2023 Sep; 35():101730. PubMed ID: 37406550
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs in lung cancer: emerging regulators of angiogenesis.
Liao Y; Wu X; Wu M; Fang Y; Li J; Tang W
J Transl Med; 2022 Aug; 20(1):349. PubMed ID: 35918758
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
Taucher V; Mangge H; Haybaeck J
Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension.
Carregal-Romero S; Fadón L; Berra E; Ruíz-Cabello J
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
